Excitement about the effectiveness and availability of blood biomarker testing for Alzheimer’s disease (AD) has created confusion around whether there’s still a need for other important tools, like cognitive screening. The answer is simple. Cognitive screening is integral to monitoring brain function and identifying impairment in older adults. (But even cognitive screening makers like Neurotrack […]
Read more
The Centers for Medicare and Medicaid Services (CMS) have taken significant steps to improve cognitive care for Medicare beneficiaries. In fact, detecting cognitive impairment is a required element of annual wellness visits (AWV). However, many healthcare providers struggle to implement effective and efficient cognitive screening strategies, resulting in missed opportunities for early detection and care. […]
Read more
Research has shown that the majority of Americans would want to know if they have Alzheimer’s disease (AD) so that they could take advantage of early treatments. Yet, most people experiencing cognitive issues are reluctant to share their concerns with their primary care physician (PCP), the providers on the front lines of diagnosing AD. While […]
Read more
Haunted by the lethal prospect of cognitive disease, I saw huge advances being made in treating cardiovascular conditions, diabetes, and cancer through screening and behavior change, and had a spark. It seemed that brain health could benefit from the same approach. But there was little medical infrastructure to make it happen.
Read more
New hire to drive business expansion amid exciting advances in Alzheimer’s treatment and care (PRESS RELEASE) Neurotrack, the leader in science-backed cognitive health solutions, announced Shawn Lemerise as its first Chief Growth Officer to support the company’s expanding business. With more than 20 years of healthcare experience, Shawn brings his expertise in the health system and provider […]
Read more
Through technological innovation, policy reform, and greater patient demand, PCPs are now in a position to integrate a quick cognitive screening into their practice offerings.
Read more
The Digital Exam Enables Providers, For The First Time Ever, To Quickly Screen Brain Health During A Typical 40-Minute Wellness Appointment, More Efficiently And Accurately Signaling Early Signs Of Cognitive Decline (PRESS RELEASE) Neurotrack, the leader in science-backed cognitive health solutions, announced today the launch of the first ever three-minute digital cognitive assessment that enables […]
Read more
Read about the results of Neurotrack’s survey of adults 60+ and their attitudes and concerns around cognitive health.
Read more
What the Failure of Biogen’s Aducanumab Tells Us About Alzheimer’s — Risk Reduction is Still Our Best Weapon Today I serve as Neurotrack’s Head Writer. But three years ago, in a different professional incarnation, I had the privilege of sitting in a packed conference room with a bright, articulate representative from the pharmaceutical company Biogen […]
Read more
With a diet rich in fish and vegetables, universal healthcare, and citizens who visit their doctors, on average, fourteen times a year, Japan boasts some of the healthiest humans on the planet. And yet the upshot of this statistically anomalous A+ on its health report card means that one fifth of Japan’s population is now […]
Read more